Foresite Capital Management IV, LLC 13F Portfolio
| Entity | Category | QoQ AUM Change | AUM (13F) | # of Holdings | Performance Rank | Equities Trend |
|---|---|---|---|---|---|---|
FC Foresite Capital Management IV, LLC | Institutional Filer | ▲ 3.21% | $237.1M | 8 |
Current Portfolio Holdings
Showing all 8 reported positions by value
| # | Stock | Company Name | Sector | Shares Held | Market Value | % of Portfolio |
|---|---|---|---|---|---|---|
| 1 | PHVS | Pharvaris N.V. | Healthcare | 4.8M | $135.0M | 56.94% |
| 2 | CYTK | Cytokinetics, Incorporated | Healthcare | 503K | $33.2M | 13.99% |
| 3 | EIKN | Eikon Therapeutics, Inc. | — | 1.9M | $20.6M | 8.67% |
| 4 | LYEL | Lyell Immunopharma, Inc. | Healthcare | 800K | $16.1M | 6.77% |
| 5 | RLAY | Relay Therapeutics, Inc. | Healthcare | 1.0M | $9.9M | 4.20% |
| 6 | XENE | Xenon Pharmaceuticals Inc. | Healthcare | 160K | $9.3M | 3.92% |
| 7 | ALEC | Alector, Inc. | Healthcare | 3.9M | $8.4M | 3.53% |
| 8 | MAZE | Maze Therapeutics, Inc. | Healthcare | 157K | $4.7M | 1.98% |
Showing 1 to 8 of 8 holdings